You are here
- Home
- Therapy Areas
- Neuroscience
A Phase I, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability and Pharmacokinetics of NKTR-118 Following Single and Multiple Ascending Oral Dose Administration in Healthy Young and Elderly Japanese Subjects, and an Open Randomized, Crossover Study to Investigate the Effect of Food on the Pharmacokinetics After Single Oral Doses of NKTR-118 in Healthy Male Japanese Subjects
- Generic Name
- NKTR-118
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Mar 23, 2011
- Study Name
- D3820C00020
- Study Id
- D3820C00020
- ClinicalTrials.gov ID
- NCT01318655
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
